Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.
Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 2014;156:663–77.
Wang H, Yang Y, Liu J, Qian L. Direct cell reprogramming: approaches, mechanisms and progress. Nat Rev Mol Cell Biol. 2021;22:410–24.
PubMed PubMed Central Google Scholar
Yin X, Zhou C, Li J, Liu R, Shi B, Yuan Q, et al. Autophagy in bone homeostasis and the onset of osteoporosis. Bone Res. 2019;7:28.
PubMed PubMed Central Google Scholar
Akkawi I, Zmerly H. Osteoporosis: current concepts. Joints. 2018;6:122–7.
PubMed PubMed Central Google Scholar
Chang Y, Cho B, Kim S, Kim J. Direct conversion of fibroblasts to osteoblasts as a novel strategy for bone regeneration in elderly individuals. Exp Mol Med. 2019;51:1–8.
Fallah A, Beke A, Oborn C, Soltys CL, Kannu P. Direct reprogramming of fibroblasts to osteoblasts: techniques and methodologies. Stem Cells Transl Med. 2024;13:362–70.
Yamamoto K, Kishida T, Sato Y, Nishioka K, Ejima A, Fujiwara H, et al. Direct conversion of human fibroblasts into functional osteoblasts by defined factors. Proc Natl Acad Sci U S A. 2015;112:6152–7.
CAS PubMed PubMed Central Google Scholar
Mizoshiri N, Kishida T, Yamamoto K, Shirai T, Terauchi R, Tsuchida S, et al. Transduction of Oct6 or Oct9 gene concomitant with Myc family gene induced osteoblast-like phenotypic conversion in normal human fibroblasts. Biochem Biophys Res Commun. 2015;467:1110–6.
Li Y, Wang Y, Yu J, Ma Z, Bai Q, Wu X, et al. Direct conversion of human fibroblasts into osteoblasts and osteocytes with small molecules and a single factor, Runx2. bioRxiv 2017:127480.
Yamamoto K, Kishida T, Nakai K, Sato Y, Kotani SI, Nishizawa Y, et al. Direct phenotypic conversion of human fibroblasts into functional osteoblasts triggered by a blockade of the transforming growth factor-beta signal. Sci Rep. 2018;8:8463.
PubMed PubMed Central Google Scholar
Cha H, Lee J, Park HH, Park JH. Direct conversion of human fibroblasts into osteoblasts triggered by histone deacetylase inhibitor valproic acid. Appl Sci. 2020;10:7372.
Liu X, Sun H, Qi J, Wang L, He S, Liu J, et al. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT–MET mechanism for optimal reprogramming. Nat Cell Biol. 2013;15:829–38.
Prakash N, Cha Y, Koh WG, Park H, Bello AB, Lee SH. Derivation of mesenchymal stem cells through sequential presentation of growth factors via gelatin microparticles in pluripotent stem cell spheroids. Biomater Res. 2025;29:0184.
PubMed PubMed Central Google Scholar
Bello AB, Canlas KKV, Kim D, Park H, Lee SH. Stepwise dual-release microparticles of BMP-4 and SCF in induced pluripotent stem cell spheroids enhance differentiation into hematopoietic stem cells. J Control Release. 2024;371:386–405.
Kim HJ, Park JS, Yi SW, Oh HJ, Kim JH, Park KH. Sequential transfection of RUNX2/SP7 and ATF4 coated onto dexamethasone-loaded nanospheres enhances osteogenesis. Sci Rep. 2018;8:1447.
PubMed PubMed Central Google Scholar
Xie X, Fu Y, Liu J. Chemical reprogramming and transdifferentiation. Curr Opin Genet Dev. 2017;46:104–13.
Qin H, Diaz A, Blouin L, Lebbink Robert J, Patena W, Tanbun P, et al. systematic identification of barriers to human iPSC generation. Cell. 2014;158:449–61.
CAS PubMed PubMed Central Google Scholar
Anokye-Danso F, Snitow M, Morrisey EE. How microRNAs facilitate reprogramming to pluripotency. J Cell Sci. 2012;125:4179–87.
CAS PubMed PubMed Central Google Scholar
Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341:651–4.
Cheng L, Hu W, Qiu B, Zhao J, Yu Y, Guan W, et al. Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res. 2014;24:665–79.
CAS PubMed PubMed Central Google Scholar
Hu W, Qiu B, Guan W, Wang Q, Wang M, Li W, et al. Direct Conversion of normal and alzheimer’s disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell. 2015;17:204–12.
Wang K, Liu H, Hu Q, Wang L, Liu J, Zheng Z, et al. Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal Transduct Target Ther. 2022;7:374.
CAS PubMed PubMed Central Google Scholar
Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001;276:36734–41.
Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 2008;26:795–7.
CAS PubMed PubMed Central Google Scholar
Baker M. Small molecules boost reprogramming rates. Nature Rep Stem Cells. 2008. https://doi.org/10.1038/stemcells.2008.99
Cha BH, Kim JS, Chan Ahn J, Kim HC, Kim BS, Han DK, et al. The role of tauroursodeoxycholic acid on adipogenesis of human adipose-derived stem cells by modulation of ER stress. Biomaterials. 2014;35:2851–8.
Cha BH, Jung MJ, Moon BK, Kim JS, Ma Y, Arai Y, et al. Administration of tauroursodeoxycholic acid enhances osteogenic differentiation of bone marrow-derived mesenchymal stem cells and bone regeneration. Bone. 2016;83:73–81.
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discovery. 2021;20:101–24.
Israelachvili JN, Mitchell DJ, Ninham BW. Theory of self-assembly of lipid bilayers and vesicles. Biochim Biophys Acta. 1977;470:185–201.
Lee S, Kim B, Lee M-J, Kim D, Park S, Kim J, et al. Curcumin-PLGA NPs coated with targeting biomimetic personalized stem cell membranes for osteoarthritis therapy. J Control Release. 2025;381:113625.
Young RN, Grynpas MD. Targeting therapeutics to bone by conjugation with bisphosphonates. Curr Opin Pharmacol. 2018;40:87–94.
Fu C, Jin X, Ji K, Lan K, Mao X, Huang Z, et al. Macrophage-targeted Mms6 mRNA-lipid nanoparticles promote locomotor functional recovery after traumatic spinal cord injury in mice. Sci Adv. 2025;11:eads2295.
CAS PubMed PubMed Central Google Scholar
Smith T, Affram K, Nottingham EL, Han B, Amissah F, Krishnan S, et al. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer. Sci Rep. 2020;10:16989.
CAS PubMed PubMed Central Google Scholar
Truong B, Allegri G, Liu XB, Burke KE, Zhu X, Cederbaum SD, et al. Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency. Proc Natl Acad Sci. 2019;116:21150–9.
CAS PubMed PubMed Central Google Scholar
Qiu M, Tang Y, Chen J, Muriph R, Ye Z, Huang C, et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2022;119:e2116271119.
CAS PubMed PubMed Central Google Scholar
Iwasaki Y, Fukaura S, Mabuchi S, Okuno Y, Yokota A, Neo M. Suppression of bone resorption in ovariectomized mice using estrogen-immobilized polyphosphodiesters. Materialia. 2024;36: 102166.
Kang HK, Park CY, Jung SY, Jo SB, Min BM. A Vitronectin-derived peptide restores ovariectomy-induced bone loss by dual regulation of bone remodeling. Tissue Eng Regen Med. 2022;19:1359–76.
Comments (0)